You are requesting information on: Ajinomoto Bio-Pharma Services Signs Manufacturing Agreement with Humanigen for Lenzilumab Currently in FDA-Approved Phase III Study for COVID-19 Ajinomoto Bio-Pharma Services
Already a member of Bioprocess Online or VertMarkets? Sign in now.
In order for our suppliers to better serve your request, please enter specific requirements or questions below: